Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

November 15, 2023 | 5:00 PM - 8:00 PM PDT

Werqwise
4 West 4th Ave
San Mateo, CA, USA 94402

Overview (Program Summary)

A program hosted by:

ACC San Francisco Bay Area

5:00PM-6:00PM   The Unified Patent Court: Friend or Foe?

6:00PM-8:00PM   Sushi Making, Networking & Cocktails

Join fellow ACC SFBA members and our sponsor, Osborne Clarke for a CLE entitled "Unified Patent Court: Friend or Foe" followed by Sushi Making, Networking & Cocktails on Werqwise's beautiful rooftop terrace with an almost 360 degree view of the Bay Area.

The introduction of the Unified Patents Court (UPC) and Unitary Patent (UP) has had a significant impact on various industries, including the life sciences and healthcare sectors. These sectors, which heavily rely on patents for innovation and research, have had to navigate the added complexity brought about by the new system. It is crucial for in-house counsel managing international IP programs in these industries to stay up to date with the evolving landscape and effectively address the challenges and opportunities presented by the UPC and UP.

Join our experts for a discussion that will include topics such as:

  • Determine which patents are eligible for unitary patent protection under the UPC system.
  • Opt-out request to avoid the jurisdiction of the UPC? Evaluate risks of centralized revocation proceedings.
  • Litigation strategies that might work for enforcing patents under the UPC system. Consider where to bring infringement actions to leverage local divisions.
  • UPC case law and trends to monitor as the court begins operation with preemptive preparation.
  • Evaluate UPC system versus the existing European national court system. Leverage the central injunction procedure.

SPEAKERS:

Will James, UK Partner, Patent and IP specialist and head of Osborne Clarke’s UK Life Sciences and Healthcare sector

Dr. Andrea Schmoll, Germany Partner, IP and licensing specialist, Osborne Clarke

Tim Harris, UK Partner, Patent litigator, Pharma and Biotech specialist, Osborne Clarke


CLE

State: California
ACC